Last reviewed · How we verify

NCT04043988

Management of Diverticulitis in the Emergency Department

Completed Last updated 3 May 2023
What this trial tests

trial in Diverticulitis in 718 participants. Completed in 30 April 2023.

Timeline
18 April 2019
Primary endpoint
30 August 2022
30 April 2023

Quick facts

Lead sponsorOlive View-UCLA Education & Research Institute
StatusCompleted
Study typeOBSERVATIONAL
Enrollment718
Start date18 April 2019
Primary completion30 August 2022
Estimated completion30 April 2023
Sites1 location across United States

Conditions studied

Sponsor

Olive View-UCLA Education & Research Institute

Who can join

18 and older, any sex, with Diverticulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to describe current treatment practices in the US for managing acute uncomplicated diverticulitis. In addition, we will identify clinical factors associated with the decision to discharge versus hospitalize patients with uncomplicated diverticulitis with the goal of informing clinical decision-making and providing a foundation for diagnostic algorithms to guide clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diverticulitis

Currently open trials in the same condition.

Other Olive View-UCLA Education & Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04043988.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing